"Our pulmonary research improves lives. The Lung Research Center is leading the effort to improve outcomes in life threatening lung diseases and is looking for candidates for research studies. Our Research Center has contributed to advances in the understanding of lung disease including innovative medical treatments that have improved quality-of-life and survival for patients. Our medical staff includes: Neil Ettinger, MD Bobby Shah, MD Kristen Fisher, MD Contact us to learn more about our current trials and if you or someone you love may qualify."

During the past decade, The Lung Research Center, LLC conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 7 clinical trials were completed, i.e. on average, 41.2% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 5 clinical trials were completed. i.e. 41.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Lung Research Center, LLC" #1 sponsor was "Boehringer Ingelheim" with 11 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "United Therapeutics" with 2 trials sponsored, "Bellerophon Pulse Technologies" with 1 trials sponsored and "Bellus Health Inc" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Lung Research Center, LLC" #1 collaborator was "Syneos Health" with 1 trials as a collaborator and "bioRASI, LLC" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "The Lung Research Center, LLC" are "Idiopathic Pulmonary Fibrosis" (11 trials), "Lung Diseases, Interstitial" (4 trials), "Interstitial Lung Disease" (2 trials), "Idiopathic Pulmonary Fibrosis (IPF)" (1 trials) and "Pulmonary Fibrosis" (1 trials). Many other conditions were trialed in "The Lung Research Center, LLC" in a lesser frequency.

Most popular intervention types in "The Lung Research Center, LLC" are "Drug" (18 trials), "Device" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Nintedanib" (6 trials), "BI 1015550" (3 trials), "Inhaled Treprostinil" (2 trials) and "PRM-151 (Zinpentraxin Alfa)" (2 trials). Other intervention names were less common.

The vast majority of trials in "The Lung Research Center, LLC" are 19 trials for "All" genders.

Currently, there are NaN active trials in "The Lung Research Center, LLC". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 10 completed trials in The Lung Research Center, LLC, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in The Lung Research Center, LLC, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".